PAVONE, FLAMINIA
 Distribuzione geografica
Continente #
AS - Asia 3.545
NA - Nord America 1.602
SA - Sud America 627
EU - Europa 602
AF - Africa 48
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 6.428
Nazione #
US - Stati Uniti d'America 1.529
SG - Singapore 1.508
CN - Cina 852
BR - Brasile 502
VN - Vietnam 346
HK - Hong Kong 329
KR - Corea 200
FR - Francia 191
IT - Italia 121
JP - Giappone 68
IN - India 66
NL - Olanda 57
GB - Regno Unito 48
DE - Germania 47
BD - Bangladesh 45
FI - Finlandia 43
AR - Argentina 41
CA - Canada 37
IL - Israele 27
MX - Messico 24
ID - Indonesia 20
EC - Ecuador 19
ZA - Sudafrica 17
CL - Cile 14
RU - Federazione Russa 14
PY - Paraguay 13
TR - Turchia 12
VE - Venezuela 12
ES - Italia 11
PE - Perù 11
IQ - Iraq 10
IE - Irlanda 9
PL - Polonia 8
UZ - Uzbekistan 8
AE - Emirati Arabi Uniti 7
AT - Austria 7
CO - Colombia 7
DZ - Algeria 7
KE - Kenya 7
SE - Svezia 7
KZ - Kazakistan 6
MY - Malesia 6
PH - Filippine 6
PK - Pakistan 6
UY - Uruguay 6
EG - Egitto 5
MA - Marocco 5
UA - Ucraina 5
CZ - Repubblica Ceca 4
JM - Giamaica 4
JO - Giordania 4
LV - Lettonia 4
AL - Albania 3
CH - Svizzera 3
DO - Repubblica Dominicana 3
GR - Grecia 3
MD - Moldavia 3
RS - Serbia 3
SA - Arabia Saudita 3
TN - Tunisia 3
AU - Australia 2
BA - Bosnia-Erzegovina 2
BH - Bahrain 2
LB - Libano 2
LK - Sri Lanka 2
LT - Lituania 2
NP - Nepal 2
TH - Thailandia 2
AZ - Azerbaigian 1
BB - Barbados 1
BG - Bulgaria 1
BJ - Benin 1
BO - Bolivia 1
BS - Bahamas 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
DM - Dominica 1
ET - Etiopia 1
GY - Guiana 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
NG - Nigeria 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
PS - Palestinian Territory 1
PT - Portogallo 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
TT - Trinidad e Tobago 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 6.428
Città #
Singapore 916
Santa Clara 601
Hefei 446
Hong Kong 320
Seoul 195
San Jose 182
Lauterbourg 170
Ho Chi Minh City 122
Ashburn 119
Beijing 115
Dallas 83
Hanoi 74
Los Angeles 55
Rome 44
São Paulo 38
Tokyo 37
Helsinki 31
Minamishinagawa 28
New York 24
Bengaluru 20
Buffalo 20
Orem 18
Haiphong 14
Amsterdam 13
Biên Hòa 13
Johannesburg 13
Rio de Janeiro 13
Dhaka 12
Montreal 12
Curitiba 11
Frankfurt am Main 11
Milan 11
Nuremberg 11
Belo Horizonte 10
Hải Dương 10
Atlanta 9
Brooklyn 9
Guangzhou 9
London 9
Toronto 9
Turku 9
Da Nang 8
Dublin 8
Düsseldorf 8
Poplar 8
Tashkent 8
Bắc Ninh 7
Campinas 7
Can Tho 7
Chennai 7
Chicago 7
Council Bluffs 7
Lima 7
Nairobi 7
Shanghai 7
Warsaw 7
Asunción 6
Elk Grove Village 6
New Delhi 6
Paris 6
Phủ Lý 6
Porto Alegre 6
Qingdao 6
Quito 6
Stockholm 6
Boardman 5
Cabo Frio 5
Guarulhos 5
Kuala Lumpur 5
Madrid 5
Manchester 5
Mexico City 5
Montes Claros 5
Munich 5
São Bernardo do Campo 5
Vienna 5
Amman 4
Bologna 4
Boston 4
Brasília 4
Buenos Aires 4
Bắc Giang 4
Caracas 4
City of London 4
Cà Mau 4
Falkenstein 4
Fortaleza 4
Guayaquil 4
Ha Long 4
Kolkata 4
La Plata 4
Maceió 4
Montevideo 4
Naples 4
Newark 4
Nha Trang 4
Ninh Bình 4
Quận Một 4
Ribeirão Preto 4
Riga 4
Totale 4.181
Nome #
Sex-specific adipose tissue's dynamic role in metabolic and inflammatory response following peripheral nerve injury 108
Impact of caloric restriction on peripheral nerve injury-induced neuropathic pain during ageing in mice 103
Pharmacological Interaction of Botulinum Neurotoxins with Excitatory and Inhibitory Neurotransmitter Systems Involved in the Modulation of Inflammatory Pain 98
Effects of age-related loss of P/Q-type calcium channels in a mice model of peripheral nerve injury 93
Botulinum Toxin B Affects Neuropathic Pain but Not Functional Recovery after Peripheral Nerve Injury in a Mouse Model 84
BoNT-A as a Possible Treatment fo Chronic Spinal Cord Injury 83
Pain-related behaviours in mice lacking the CaV2.1alpha1 subunit of PQ-type Ca2+ channels 82
Central injection of botulinum neurotoxins: toxicology, brain localization and bahavioural effects in mice 77
The Rac GTPase-activating bacterial protein toxin CNF1 induces analgesia up-regulating mu-opioid receptors 77
null 75
The novel reversible fatty acid amide hydrolase inhibitor ST4070 increases endocannabinoid brain levels and counteracts neuropathic pain in different animal models 71
Sex Differences in Neuropathy: The Paradigmatic Case of MetFormin 70
Xeomin((R)), a Commercial Formulation of Botulinum Neurotoxin Type A, Promotes Regeneration in a Preclinical Model of Spinal Cord Injury 70
Very Early Involvement of Innate Immunity in Peripheral Nerve Degeneration in SOD1-G93A Mice 69
Altered pain sensitivity in mice lacking the CaV2.1alpha1 subunit of P/Q-type Ca2+ channels 68
Revealing the Therapeutic Potential of Botulinum Neurotoxin Type A in Counteracting Paralysis and Neuropathic Pain in Spinally Injured Mice 66
Sexually dimorphic immune and neuroimmune changes following peripheral nerve injury in mice: novel insights for gender medicine 64
Innovative mouse model mimicking human-like features of spinal cord injury: efficacy of Docosahexaenoic acid on acute and chronic phases 64
The effect of botulinum neurotoxin A on sciatic nerve injury-induced neuroimmunological changes in rat dorsal root ganglia and spinal cord 63
Botulinum toxin type a as a therapeutic agent against headache and related disorders 61
Shuttle-box avoidance learning in mice: improvement by combined glucose and tacrine. 60
Botulinum neurotoxins and formalin-induced pain: central vs. peripheral effects in mice. 60
Participation of pro- and anti-nociceptive interleukins in botulinum toxin A-induced analgesia in a rat model of neuropathic pain 60
EFFECTS OF BOTULINUM NEUROTOXIN TYPE B IN NEUROPATHIC MICE: BEHAVIORAL AND IMMUNOHISTOCHEMICAL INVESTIGATIONS 60
Central injection of botulinum neurotoxins: behavioural effects in mice. 58
Nuova applicazione terapeutica della neurotossina botulinica sierotipo A 58
The role of glial cells in the experience of pain: how much is important the sex factor? 58
Habit learning in the cross maze: a cross talk between the context and the goal for action control. 56
Sex differences and modulatory effect of 17beta-estradiol on behavioral and immune responses in neuropathic mice. 54
METHOD FOR THE POTENTIATION OF OPIOID ANALGESICS EFFECTS ON PAIN 53
D-aspartate modulates nociceptive-specific neuron activity and pain threshold in inflammatory and neuropathic pain condition in mice 53
Przeciwbólowe efekty toksyny botulinowej A w szczurzym modelu bólu neuropatycznego. 53
The influence of BoNT/A administration on IL-1 family members in rat neuropathic pain model - in vivo and in vitro evidences. 52
In vitro receptor binding properties of a painless NGF mutein, linked to Hereditary Sensory Autonomic Neuropathy type V 50
Intranasal "painless" human Nerve Growth Factors slows amyloid neurodegeneration and prevents memory deficits in App X PS1 mice 50
17beta-estradiol counteracts neuropathic pain: a behavioural, immunohistochemical, and proteomic investigation on sex-related differences in mice. 50
Comparison of the expression changes after botulinum toxin type a and minocycline administration in lipopolysaccharide-stimulated rat microglial and astroglial cultures 50
Clostridial neurotoxins: new tools for the studyof the pharmacology of pain 49
Botulinum neurotoxin A promotes functional recovery after peripheral nerve injury by increasing regeneration of myelinated fibers 49
Schwann cell autophagy counteracts the onset and chronification of neuropathic pain 49
A new clinical relevant murine model of spinal cord injury mimicking the pathological features of complete paralysis in humans. 48
Higher pain perception and lack of recovery from neuropathic pain in females: A behavioural, immunohistochemical, and proteomic investigation on sex-related differences in mice 48
Morphine and memory in DBA/2 mice: effects of stress and of prior experience. 47
Rac-dependent pathway and cytoskeleton remodeling: a newintracellular mechanism for modulation of inflammatory pain 47
Botulinum neurotoxin type A counteracts neuropathic pain and facilitates functional recovery after peripheral nerve injury in animal models. 46
CNF1 BACTERIAL TOXIN PROTEIN FROM E. COLI AS ANALGESIC 45
Differenze sessuali nello sviluppo del dolore neuropatico in un modello animale: il contributo delle cellule gliali 45
Is BoNT/B useful for pain treatment? 43
Long term effect of neonatal inflammatory on pain sensitivity and social behaviour in mice 43
Reduction of oxotremorine-induced analgesia after chronic but not acute restraint stress 42
Altered sensitivity to nociceptive stimuli in mice lacking the CaV2.1 alpha1 subunit of P/Q-type Ca2+ channels. 41
TLQP-21, a VGF-derived peptide, increases energy expenditure and prevents the early phase of diet-induced obesity 41
Remission of hair loss and induction of hair regrowth by botulinum neurotoxin A in mice 40
Implication of the VGF-derived peptide TLQP-21 in mouse acute and chronic stress responses 40
Pain sensitivity in mice lacking the Ca(v)2.1alpha1 subunit of P/Q-type Ca2+ channels. 40
Botulinum toxin A increases analgesic effects of morphine, counters development of morphine tolerance and modulates glia activation and ? opioid receptor expression in neuropathic mice. 40
Cognitive and neural determinants of response strategy in the dual-solution plus-maze task 40
Attenuation of cholinergic analgesia by nifedipine. 39
Chronic intracerebroventricular TLQP-21 delivery does not modulate the GH/IGF-1-axis and muscle strength in mice. 39
Role of Schwann cell autophagy in an animal model of neuropathic pain: functional and structural investigations 38
ProNGF\NGF imbalance triggers learning and memory deficits, neurodegeneration and spontaneous epileptic-like discharges in transgenic mice. 38
Botulinum neurotoxin serotype A: an innovative pharmacological approach for pain treatment. 36
The Analgesic Effect on Neuropathic Pain of Retrogradely Transported botulinum Neurotoxin A Involves Schwann Cells and Astrocytes 36
Nifedipine-morphine interaction: a further investigation on nociception and locomotor activity in mice. 35
Studies on a new series of THA analogues: effects of the aromatic residues that line the gorge of AchE 35
Effects of sauvagine on behavioural arousal of mice. 35
Is the retrograde transport of botulinum neurotoxin type A involved in its analgesic effects on neuropathic pain? 35
Uso di molecole in grado di inibire il legame tra NGF e il suo recettore TrkA come analgesici ad effetto prolungato (Use of molecules able to block the NGF - TrkA binding as analgesic drugs with long lasting effects) 34
Botulinum neurotoxin serotype A improves behavioural responses and peripheral nerve regeneration in a mouse model of neuropathic pain 34
Attenuation by nimodipine of amitriptyline-induced avoidance impairment in mice. 32
The interaction of tetrahydroisoquinoline derivatives with antinociceptive action of morphine and oxotremorine in mice 32
Toxicological and behavioural effects of botulinum neurotoxins injected in central nervous system 32
Altered sensitivity to nociception stimuli in mice lacking the CaV2.1alpha1 subunit of PQ-type Ca2+ channels 32
Central injection of botulinum neurotoxins: toxicology and behavioural effects in mice 31
Modulation of nociception by social factors in rodents: contribution of the opioid system 31
Botulinum neurotoxin serotype A and morphine: a successful pharmacological combination for treating inflammatory pain 30
Taking Pain Out of NGF: A "Painless" NGF Mutant, Linked to Hereditary Sensory Autonomic Neuropathy Type V, with Full Neurotrophic Activity 30
Toxicity of botulinum neurotoxins in central nervous system of mice 30
Behavioral and immunohistochemical sex-related differences in neuropathic mice. 30
Single cycle structure-based humanization of an anti-nerve growth factor therapeutic antibody 30
The effect of botulinum neurotoxin A on CCI-Induced neuroimmunological chnages in DRG and spinal cord 28
Formalin hindpaw injection induces changes in the [(3)H]prazosin binding to alpha(1)-adrenoceptors in specific regions of the mouse brain and spinal cord. 28
The function neutralizing anti-TrkA antibody MNAC13 reduces inflammatory and neuropathic pain. 28
Age-related cholinergic drug effects on analgesia in two inbred strains of mice 27
New analogs of physostigmine: alternative drugs for Alzheimer's disease? 27
Analgesic effects of the bacterial protein toxin CNF1 in inflammatory pain. 27
Morphine and botulinum neurotoxin A: a successful pharmacological combination against pain? 27
Document Postnatal administration of phosphatidylserine in C57BL/6 mice : Effects on development and learning abilities 26
Botulinum neurotoxins: new frontiers in neuropathic pain therapy? 26
The bacterial protein toxin CNF1 induces analgesic effects and upregulates mu opioid receptors in a model of neuropathic pain 26
Alterations of neuroexocytosis induced by botulinum neurotoxins: behavioural effects in mice 26
Declarative and habitual learning in the cross maze: effects of outcome devaluation and botulinum neurotoxin A injection into the straiatal complex of CD1 mice. 26
Serotonergic influence on cholinergic-induced analgesia: differences in two inbred strains of mice. 25
The VGF-derived peptide TLQP-21: a new modulatory peptide for inflammatory pain 25
Altered pain sensitivity in mice lacking the CaV2.1?1 subunit of P/Q-type Ca2+ channels. 25
Uso di molecole in grado di bloccare l'attività di TrkA per potenziare gli effetti di analgesici oppiacei sul dolore (Use of molecules able to block the TrkA activity for powering the analgesic effects of opioids on pain). 25
Treadmill exercise counteracts neuropathic pain, reduces spinal glial cells expression and enhances regeneration after sciatic nerve injury 25
Similar effects of nifedipine and hydralazine on anaesthesia and hypermotility induced by pentobarbitone in mice. 25
M2 receptors exert analgesic action on DRG sensory neurons by negatively modulating VR1 activity 25
Intrathecal oxotremorine affects formalin-induced behavior and spinal nitric oxide synthase immunoreactivity in rats. 25
Totale 4.660
Categoria #
all - tutte 19.367
article - articoli 12.378
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.745


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202446 0 0 0 0 0 0 0 0 5 3 32 6
2024/20252.352 11 8 183 114 500 120 28 76 38 64 624 586
2025/20264.053 249 526 474 670 674 144 607 237 166 230 76 0
Totale 6.451